mitoxantrone has been researched along with Central Nervous System Neoplasms in 4 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Central Nervous System Neoplasms: Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The relative increased risk of breast cancer in MS women under IS treatment warrants further attention." | 1.35 | Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis. ( Berthier, F; Clavelou, P; Danzon, A; de Seze, J; Debouverie, M; Defer, G; Gout, O; Lebrun, C; Rumbach, L; Vermersch, P; Wiertlevski, S, 2008) |
| "Superior sagittal sinus thrombosis (SSST) has been reported to be caused by coagulopathy following oral contraceptive therapy, DIC, infection around the sinus, compression from a tumor, infiltration of tumor, and an inherited deficiency of proteins C and S, but SSST associated with hematological malignancies and L-asparaginase (L-Asp) therapy is rare." | 1.33 | [Superior sagittal sinus thrombosis during remission induction therapy for acute lymphoblastic leukemia]. ( Iijima, K; Iki, S; Kida, M; Nakasone, H; Taoka, K; Urabe, A; Usuki, K; Yoshimi, A, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, X | 1 |
| Wang, Y | 1 |
| Sun, X | 1 |
| Bai, X | 1 |
| Cui, Q | 1 |
| Zhu, H | 1 |
| Qian, J | 1 |
| Chen, Y | 1 |
| Sun, S | 1 |
| Ji, N | 1 |
| Liu, Y | 1 |
| Yoshimi, A | 1 |
| Taoka, K | 1 |
| Nakasone, H | 1 |
| Iijima, K | 1 |
| Kida, M | 1 |
| Iki, S | 1 |
| Urabe, A | 1 |
| Usuki, K | 1 |
| Yamanaka, R | 1 |
| Homma, J | 1 |
| Sano, M | 1 |
| Tsuchiya, N | 1 |
| Yajima, N | 1 |
| Takahashi, H | 1 |
| Shinbo, Y | 1 |
| Hasegawa, A | 1 |
| Saitoh, T | 1 |
| Tanaka, R | 1 |
| Lebrun, C | 1 |
| Debouverie, M | 1 |
| Vermersch, P | 1 |
| Clavelou, P | 1 |
| Rumbach, L | 1 |
| de Seze, J | 1 |
| Wiertlevski, S | 1 |
| Defer, G | 1 |
| Gout, O | 1 |
| Berthier, F | 1 |
| Danzon, A | 1 |
1 trial available for mitoxantrone and Central Nervous System Neoplasms
| Article | Year |
|---|---|
Salvage immuno-chemotherapy with a combination of rituximab, high-dose cytarabine, mitoxantrone and dexamethasone for patients with primary CNS lymphoma: a preliminary study.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2007 |
3 other studies available for mitoxantrone and Central Nervous System Neoplasms
| Article | Year |
|---|---|
STAT3 Activation Is Associated with Interleukin-10 Expression and Survival in Primary Central Nervous System Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 2020 |
[Superior sagittal sinus thrombosis during remission induction therapy for acute lymphoblastic leukemia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neoplasm | 2006 |
Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.
Topics: Adult; Azathioprine; Breast Neoplasms; Central Nervous System Neoplasms; Cyclophosphamide; Digestive | 2008 |